Sphingolipids are multifunctional lipids and a major constituent of the cell membranes of eukaryotes. Although the fatty acid (FA) moiety of sphingolipids is usually a saturated or monounsaturated FA, polyunsaturated FA (PUFA)-containing species also exist in mammalian tissues. In the present study, we showed that C24:2 PUFA-containing ceramide is one of the seven major ceramide species in a wide range of tissues. C24:2 ceramide levels were especially high in spleen and small intestine; in the former, it was the fourth most abundant ceramide species. However, both the synthetic pathway and the physiological function of C24:2 ceramide had yet to be identified. Tracer analysis using deuterium-labeled linoleic acid (C18:2) revealed that C24:2 ceramide is produced via elongation of linoleic acid.
Introduction
Sphingolipids, together with glycerophospholipids and cholesterol, constitute the biological membranes of eukaryotes. Sphingolipids play several important physiological roles including in neural function, skin barrier formation, regulation of glucose metabolism, recognition of bacterial toxins and viruses, spermatogenesis, immunity, and vascular formation and function [1] [2] [3] [4] [5] . They are enriched in the outer leaflet of plasma membranes, where they cluster to form so-called lipid microdomains [6, 7] . These structures serve as platforms where many cell signaling proteins accumulate to promote efficient signal transduction.
Complex sphingolipids-i.e., sphingomyelin and glycosphingolipids in mammals-consist of the hydrophobic backbone ceramide and a polar head group (phosphocholine in sphingomyelin and a saccharide chain in glycosphingolipids). Mammals possess hundreds of glycosphingolipid species that differ in their sugar residues and linking modes [5] . The simplest among these are glucosylceramide and galactosylceramide, having only one glucose and galactose residue respectively; they are collectively referred to as monohexosylceramides (HexCers) or cerebrosides.
Ceramide is composed of a long-chain base (LCB) and a fatty acid (FA). LCBs commonly contain hydroxyl groups at C1 and C3 and an amino group at C2 [5, 8] . These functional groups act as donors and acceptors of hydrogen bonds to form lipid microdomains.
In contrast, glycerophospholipids have only acceptors for hydrogen bonds but no hydrogen bond donors. The major mammalian LCB is sphingosine (d18:1; where d indicates 2 (double) hydroxyl groups; 18, carbon chain length; 1, number of double bonds) with a trans double bond between C4 and C5. Mammals also have other LCBs including sphingadienine (d18:2)-which contains a trans double bond between C4 and C5 and a cis double bond between C14 and C15-and saturated dihydrosphingosine (d18:0) [8, 9] .
According to chain length, cellular FAs can be classified into long-chain FAs (LCFAs) with C11-C20 and very long-chain (VLC) FAs (VLCFAs) with ≥C21 [10, 11] . FA compositions differ between glycerophospholipids and sphingolipids. Most glycerophospholipids contain LCFAs as their FA moiety [12] , while many sphingolipids contain VLCFAs, especially C24:0 and C24:1 FAs. About 30-70% of sphingomyelins containing VLCFAs, with specific proportions varying among tissues [11] . In addition, glycerophospholipids often contain polyunsaturated FAs (PUFAs) such as linoleic acid (C18:2) and arachidonic acid (C20:4), mostly at the sn-2 position [12] . Since the cis double bonds of PUFAs are bent in membranes, glycerophospholipids do not readily cluster with each other. In contrast, the FA moiety of sphingolipids is mainly saturated C16-C24, although monounsaturated sphingolipids with C24:1 also exist ubiquitously [11] . PUFA-containing sphingolipids have only been reported in limited tissues/cells at low levels [13] [14] [15] [16] [17] . An exception is spermatozoa (and possibly the surrounding testis), which possesses relatively high amounts of PUFA-containing sphingolipids with ≥C28 [18] . Sphingolipids are typically characterized by hydrophobic chains that do not have cis double bonds, allowing the lipids to pack tightly and create hydrophobic interactions, which are further enhanced by long FA chain length. The presence of hydrogen bond donors/acceptors and saturated VLCFAs in sphingolipids drive the formation of lipid microdomains.
Mammals absorb LCFAs from their diet; palmitic acid (C16:0) specifically can also be produced by FA synthase. Fractions of these LCFAs are elongated to VLCFAs via the FA elongation cycle in the endoplasmic reticulum [10, 11] . In each cycle, the FA substrate in 6 acyl-CoA form is elongated by 2 carbons. The rate-limiting step of the cycle is catalyzed by FA elongases, of which mammals have seven varieties (ELOVL1-7) with different substrate specificities ( Fig. 1 ) [5, 10, 11] . Mammals can produce the monounsaturated FAs palmitoleic acid (C16:1) and oleic acid (C18:1) from palmitic acid and stearic acid (C18:0), respectively, by ∆9 desaturase. However, since mammals lack both ∆12 and Δ15 desaturases, they cannot produce the n-6 PUFA linoleic acid (C18:2) or the n-3 PUFA α-linolenic acid (C18:3), which must therefore be absorbed from dietary sources. Fractions of these PUFAs are elongated by ELOVLs and desaturated by Δ5 and/or Δ6 desaturases to become other n-6 and n-3 PUFAs ( Fig. 1 ). Ceramide synthases produce a ceramide using an acyl-CoA molecule and a LCB as substrates. Mammals have six ceramide synthases (CERS1-6) with different substrate specificities ( Fig. 1 ) [5, [19] [20] [21] . Of these, CERS2 is known to be involved in the production of C22 and C24 ceramides [13, 19, 21, 22] .
Recent developments in mass spectrometry (MS) now allow lipid molecules to be analyzed in detail. In particular, triple quadrupole-type mass spectrometers can distinguish among lipids having the same molecular mass but different structures by tandem mass spectrometry (MS/MS) [23] . For example, d18:1-C24:1 ceramide and d18:2-C24:0 ceramide have the same molecular mass but can be distinguished by the differences in their daughter ions. Combining liquid chromatography (LC) with triple quadrupole MS makes it possible to separate and identify even more lipid species. In the present study, we used LC-MS/MS to perform detailed analyses on ceramide species from various mouse tissues. Although PUFA-containing sphingolipids had only been reported in limited tissues [14] [15] [16] [17] [18] , we found here that C24:2 sphingolipids exist relatively abundantly in a wide range of tissues.
Furthermore, we revealed the synthetic pathway of C24:2 ceramide. units/ml penicillin, and 100 μg/ml streptomycin.
Mice
C57BL/6J mice were purchased from Sankyo Labo Service Corporation (Tokyo, Japan).
Elovl1 -/-Tg(IVL-Elovl1) mice have been described previously [25] . Mice were housed in a 
LC-MS/MS analysis
Lipids were extracted from spleen and small intestine tissue (~50 mg) collected from were detected in negative ion mode via multiple reaction monitoring, by selecting specific m/z (mass to charge ratio) values for the quadrupole mass filters Q1 and Q3 (Tables S1-S5) with specific collision energies (ceramides, 32 eV; sphingomyelins, 60 eV, HexCers, 40 eV; PCs, 50 eV; and PIs, 55 eV). MassLynx software (Waters) was used for data analysis and quantification.
Lipid labeling assay
HeLa cells were incubated with 5 μM d 11 -linoleic acid (Cayman Chemical, Ann Arbor, MI, USA), having 11 deuterium atoms per molecule, at 37 °C for 48 h. Lipids were extracted and dried as described previously [28] . For measuring sphingomyelins, dried lipids were dissolved in 225 μl chloroform/methanol (1:1, v/v) and subjected to alkaline treatment to hydrolyze PC, the presence of which can confound sphingomyelin measurement, as follows.
Samples were incubated with 71 μl of 0.5 M NaOH for 1 h at 37 °C, then neutralized with 35.5 μl of 1 M formic acid. Lipids were extracted by successive additions of 106.5 μl of chloroform and 219 μl of water with mixing. Phases were separated by centrifugation, and the organic phase was recovered, dried, dissolved in chloroform/methanol (1:2, v/v), and analyzed by LC-MS/MS as described above.
Construction of CERS2 knockout (KO) HAP1 cells
CERS2 KO cells were produced by a CRISPR/Cas9 nickase system using HAP1 cells.
The all-in-one CRISPR/Cas9 vector pYU417 consists of a Cas9 D10A mutant nuclease (Cas9 nickase), a guide RNA cloning cassette, EGFP, and the puromycin N-acetyltransferase gene [28] . For production of two guide RNAs (guide RNA 1 and guide RNA 2; Fig. S1 ) targeted to 
Preparation of detergent-resistant membrane (DRM) fraction
HeLa cells cultured in a 150 mm dish were washed with PBS, suspended in 870 μl of concentrated by the chloroform-methanol method as described previously [29] .
Immunoblotting
Proteins separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis were 
Results

C24:2 ceramide exists in a wide range of mouse tissues
Eleven mouse tissues (brain, lung, heart, skeletal muscle, spleen, kidney, liver, colon, small intestine, epidermis, and testis) were checked for levels of sphingosine (d18:1)-containing ceramide species using LC-MS/MS. In this analysis, the m/z value 264.3, which corresponds to a part of the sphingosine molecule [23] , was used for daughter ion selection with the aim of only measuring sphingosine-containing ceramides (i.e., not measuring ceramides containing other LCBs). In all tissues examined except for epidermis and testis, seven ceramide species (C16:0, C18:0, C20:0, C22:0, C24:0, C24:1, and C24:2 ceramides) were predominant: their sum accounted for >95% of total ceramide content ( Fig.   2A ; for other ceramide species, see Table S6 ). Of these species, knowledge about C24:2 ceramide is the most limited: there are only a few reports of its existence [13] [14] [15] [16] [17] . However, C24:2 ceramide was detected in a wide range of tissues, existing most abundantly in spleen, followed in descending order by small intestine, colon, lung, and liver ( Fig. 2A) . In spleen, C24:2 ceramide was the fourth most abundant ceramide species following C24:1, C24:0, and C22:0, and accounted for 10.8% of total ceramide content. Some polyunsaturated ceramides other than C24:2 ceramide was also observed, albeit at much lower levels (Table S6 ).
Ceramides containing ≥C26 FAs were almost absent in most tissues, but notable levels were detected in epidermis and testis ( Fig. 2B and C and Table S6 ), consistent with previous reports [5, 18, 30] . Fig. 2B and 2C list the top 15 and top 12 ceramide species in epidermis and testis, respectively. Most epidermal ceramides contained saturated and monounsaturated FAs, whereas testis ceramides contained PUFAs, with C30:5 being most abundant. The total amount of ceramide was highest in the epidermis, at levels 28-80 times higher than in the other tissues ( Fig. 2D ). Ceramide's abundance in the epidermis can be attributed to its high prevalence in lipid lamellae, multilayered lipid structures that form permeable barriers in the stratum corneum, the outermost epidermis layer [5, 31] . In descending order, the most common ceramide species in epidermis were C26:0, C24:0, C28:0, C26:1, and C22:0.
Moreover, substantial amounts of C18:1, C26:1, C28:1, C32:1, and C34:1 unsaturated ceramides existed specifically in epidermis (Fig. 2B) . These results indicate that the only polyunsaturated ceramide species with ubiquitous presence in tissues is C24:2.
C24:2 FA is derived from linoleic acid
The synthetic pathway of C24:2 ceramide has yet to be clarified. We speculated that C24:2 FA is produced from linoleic acid (C18:2) by three rounds of FA elongation, which is then catalyzed to the corresponding ceramide, composed of the C24:2 FA and sphingosine. To test this hypothesis, tracer analysis was performed using deuterium (d 11 )-labeled linoleic acid.
Incubation of HeLa cells with 5 μM d 11 -linoleic acid for 48 h resulted in production of d 11 -C24:2 ceramide at levels equivalent to non-labeled C24:2 ceramide (Fig. 3A) . Few d 11 -labeled C18:2, C20:2, or C22:2 ceramides were detected. Next, levels of HexCer species in the HeLa cells were measured using the sphingosine-specific m/z value 264.3. Again, d 11 -C24:2 HexCer was detected at levels similar to those of non-labeled C24:2 species (Fig.   3B ).
In MS/MS of sphingomyelin, the daughter ion derived from phosphocholine (m/z value 184.1) was dominant, while the peak corresponding to the daughter ion derived from sphingosine was too small to be used [23] . Therefore, our analysis could not identify the specific LCB components of sphingomyelins. captured by our measurements is actually d18:1-C24:2 sphingomyelin. We therefore refer to C42:3 sphingomyelin measurements below as C24:2 sphingomyelin, for simplicity. In conclusion, the C24:2 FA portion of C24:2 ceramide is derived from linoleic acid, and C24:2 ceramide is converted to both C24:2 HexCer and C24:2 sphingomyelin.
To investigate whether C24:2 FA is specific to sphingolipids or is also a constituent of glycerophospholipids, we examined molecular species of the glycerophospholipids PC and PI in HeLa cells by LC-MS/MS. The major FA components of PC were C16:0, C16:1, and C18:1 FAs, whereas those of PI were C16:0, C16:1, C18:0, C18:1, and C20:4 FAs ( Fig. 3D and E). Almost no PC or PI contained C24:2 FA. Saturated or monounsaturated VLCFAs (C22:0, C22:1, C24:0, and C24:1), which exist in sphingolipids, were also not detected in PC or PI. Thus, our results suggest C24:2 FA exists specifically in sphingolipids.
3.3. The FA elongase ELOVL1 is involved in C24:2 FA production C24:2 FA is produced from linoleic acid via three rounds of FA elongation cycles in a CoA form. In our previous in vitro analysis, among the seven FA elongases (ELOVL1-7)
present in mammals, ELOVL3 exhibited high activity toward C18:2-CoA, while ELOVL5, ELOVL6, and ELOVL7 showed weak activity [32] . This suggests that ELOVL3 is mainly involved in the first of the three FA elongation cycles. The ELOVLs involved in the second (elongation from C20:2 to C22:2) and third cycle (elongation from C22:2 to C24:2) have not yet been determined. ELOVL1 is involved in the elongation of saturated and monounsaturated C20 and C22 FAs [25, 30, 32] . To investigate the involvement of ELOVL1 in C24:2 FA production, we utilized recently produced Elovl1 mutant mice (Elovl1 -/-Tg(IVL-Elovl1)), in which Elovl1 is disrupted in the whole body except for the epidermis [25] .
These mice were produced to circumvent the neonatal lethality observed in conventional Elovl1 KO mice due to skin barrier defects [30] . Lipids were extracted from the spleen and small intestine, the two tissues with the highest amount of C24:2 ceramide in wild type mice ( Fig. 2A) , and ceramide species were measured by LC-MS/MS. In spleen, C24:0, C24:1, and C24:2 ceramides were decreased in Elovl1 -/-Tg(IVL-Elovl1) mice compared to wild type mice, whereas ≤C22 ceramides were increased ( Fig. 4A and Table S7 ). In small intestine of Elovl1 -/-Tg(IVL-Elovl1) mice, C24:0, C24:1, C24:2, and C22:0 ceramides were decreased, while C22:1 and ≤C20 ceramides were increased ( Fig. 4B and Table S7 ). Thus, C24:2 ceramide was decreased by Elovl1 disruption in both tissues, indicating that ELOVL1 is involved in C24:2 FA production.
The ceramide synthase CERS2 is involved in C24:2 ceramide synthesis
Mammals have six ceramide synthases (CERS1-6), each showing characteristic substrate specificity (Fig. 1 ) [5] . Of these, CERS2 catalyzes saturated and monounsaturated C22 and C24 ceramide production [13, 19, 21, 22] . To investigate the involvement of CERS2 in C24:2 ceramide production, CERS2 KO cells were produced with a CRISPR/Cas9 system using near-haploid human cell line HAP1 [24] . We obtained three CERS2 KO clones with a 40 bp, 247 bp, and 41 bp deletion, respectively, in and around the exon 2 of CERS2 (Fig. S1 ).
Expression levels of CERS genes in wild type and CERS2 KO HAP1 cells were examined by quantitative real-time RT-PCR. All CERS genes were expressed in HAP1 wild type cells, with CERS2 having the highest expression ( Fig. 5A) . Expression levels of the CERS1, CERS3, CERS4, CERS5, or CERS6 were almost unaffected by the CERS2 deletions. In addition, CERS2 expression was comparable in wild type and CERS2 KO cells, indicating that the deletions affected neither the synthesis nor stability of the CERS2 mRNA.
Examination of the ceramide composition in wild type HAP1 cells by LC-MS/MS revealed that C24:0 and C24:1 ceramides were abundant (Fig. 5B ), reflecting the high expression levels of CERS2. In CERS2 KO HAP1 cells, levels of C24:2 ceramide, in addition to C22:1, C24:0, and C24:1 ceramides, were reduced compared to wild type cells. In contrast, increases in C18:0 and C20:0 ceramide levels were observed in the CERS2 KO cells. These results indicate that CERS2 is involved in C24:2 ceramide synthesis.
C24:2 sphingomyelin localizes outside lipid microdomains
Sphingomyelin is known to form lipid microdomains with cholesterol [7, 33] . The bent structure of the cis double bond in the FA portions of lipids increases intermolecular distances and weakens lipid-lipid interactions. Most glycerophospholipids contain unsaturated FAs with cis double bonds. In contrast, many sphingolipids have one trans double bond in the LCB moiety (sphingosine), while the FA moiety is saturated. This structural characteristic allows for tight packing of sphingolipids and encourages lipid microdomain formation. Since C24:2 sphingomyelin has two cis double bonds, we speculated that it is less able to form lipid microdomains than other sphingomyelin species. To clarify this, we performed a DRM assay, a simple assay for lipid microdomain localization. The non-ionic detergent Triton X-100 was added to HeLa cells, then DRMs were prepared by sucrose density gradient centrifugation.
Fraction 3, containing the lipid microdomain marker caveolin-1, was subjected to LC-MS/MS analysis of sphingomyelin species (Fig. 6A ). Although saturated sphingomyelins tended to be enriched in the lipid microdomain fraction, the proportion of monounsaturated sphingomyelins was lower than that in the total lipid sample. C24:2 sphingomyelin was even less present in the lipid microdomain fraction; although it accounted for ~7% of total sphingomyelin, it only made up ~2% of the fraction. These results suggest that unsaturated sphingomyelin, especially C24:2 sphingomyelin with two cis double bonds, tends to localize outside lipid microdomains.
Discussion
In the present study, we examined in detail the ceramide species of mouse tissues and human cells (HeLa and HAP1 cells) by LC-MS/MS analysis, and found that C24:2 ceramide was one of the top seven ceramide species (together with C16:0, C18:0, C20:0, C22:0, C24:0, and C24:1) in a wide range of tissues and cells (Figs. 2, 3 , and 5 and Table S6 ). C24:2 ceramide was particularly abundant in spleen, at the third highest levels among ceramide species. C24:2 ceramide was the only common species among polyunsaturated ceramides.
To date, conversion to γ-linolenic acid (C18:3) by Δ6 desaturase is the only known FA metabolic pathway of linoleic acid (C18:2). However, in the present study, we revealed another FA metabolic pathway of linoleic acid: elongation to C24:2 FA. Our previous in vitro analysis revealed that ELOVL3 exhibits high activity toward C18:2-CoA, whereas ELOVL5, ELOVL6, and ELOVL7 show weak activity [32] . In that experiment, ELOVL1, ELOVL2, or ELOVL4 had no activity at all toward C18:2-CoA. Therefore, it is highly likely that conversion from C18:2-CoA to C20:2-CoA is mainly catalyzed by ELOVL3. On the other hand, in the present study we found that the amount of C24:2 ceramide in spleen and small intestine of Elovl1 -/-Tg (IVL-Elovl1) mice was much lower than in corresponding wild type tissues ( Fig. 4) , indicating that ELOVL1 is involved in the conversion of C20:2-CoA to C22:2-CoA and/or C22:2-CoA to C24:2-CoA ( Fig. 7) . To date, ELOVL1 has only been known to act on saturated and monounsaturated VLC acyl-CoAs. Our results therefore indicate the novel discovery of C22:2-CoA and/or C24:2-CoA as the only polyunsaturated substrate(s) of ELOVL1. In the CERS2 KO HAP1 cells, C24:2 ceramide levels were lower than in the control HAP1 cells (Fig. 5B) , indicating that the C24:2-CoA produced by ELOVL1 is then converted to C24:2 ceramide by CERS2 (Fig. 7) .
Although both glycerophospholipids and sphingolipids contain FAs, these lipid classes vary greatly in their specific FA moieties. Glycerophospholipids mainly contain saturated, monounsaturated, and polyunsaturated LCFAs [12] (Fig. 3D and E) . Sphingolipids also have
LCFAs, but most of them are saturated [11] ( Fig. 2A and Table S6 ). In addition, C22:0, C24:0, and C24:1 FAs as well as C24:2 FA are specific to sphingolipids (Figs. 2 and 3) . bonds broaden the distance between lipids, and thus weaken hydrogen bonds and hydrophobic interactions. We attribute the reason why more saturated sphingomyelins than monounsaturated sphingomyelins were observed in the lipid microdomain fraction to this property (Fig. 6B ). In addition, C24:2 sphingomyelin comprised a smaller proportion of the lipid microdomain fraction than of total membrane lipids in our DRM assay. This result suggests that unsaturated sphingolipids negatively regulate lipid microdomain formation.
However, it has been noted that DRM assays may not necessarily reflect the precise composition of lipid microdomains in living cells [7] . Further in vitro studies are needed to clarify the differences in the physical properties of C24:2 sphingolipids and saturated/monounsaturated sphingolipids as well as the role of C24:2 sphingolipids in lipid 22 microdomain formation. 
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